Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Am Acad Dermatol ; 84(3): 644-653, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32561372

RESUMO

BACKGROUND: Complications involving internal organs are usually present in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). However, pancreatic complications are rarely reported and studied. OBJECTIVE: To summarize clinical characteristics of SJS/TEN-associated acute pancreatic injuries and to investigate underlying inflammatory mechanisms. METHODS: Clinical records of 124 inpatients with SJS/TEN were reviewed. Serum levels of tumor necrosis factor α, interleukin (IL) 6, IL-18, IL-15, IL-12p70, and soluble CD56 were determined in 18 healthy donors and 17 patients with SJS/TEN, including 3 with acute pancreatic injuries. RESULTS: Acute pancreatic injury was diagnosed in 7.3% of patients (9/124) in the SJS/TEN cohort. Elevation of serum transaminase level and hypoalbuminemia occurred more frequently in patients with acute pancreatic injuries compared with those without pancreatic symptoms (P = .004 and <.001, respectively). Although acute pancreatic injury did not alter mortality rate of SJS/TEN, it was associated with longer hospitalization stays (P = .008). Within the serum cytokines whose levels were elevated in SJS/TEN, only IL-18 was found to be selectively increased in patients with acute pancreatic injuries compared with those without them (P = .03). LIMITATIONS: Cohort was small. CONCLUSION: Acute pancreatic injury is a gastrointestinal complication of SJS/TEN in which hepatotoxicity is more likely to occur. Overexpression of IL-18 might be involved in this unique entity.


Assuntos
Interleucina-18/sangue , Pancreatite/imunologia , Síndrome de Stevens-Johnson/complicações , Adolescente , Adulto , Idoso , Antígeno CD56/sangue , Antígeno CD56/imunologia , Criança , Feminino , Humanos , Interleucina-12/sangue , Interleucina-12/imunologia , Interleucina-15/sangue , Interleucina-15/imunologia , Interleucina-18/imunologia , Interleucina-6/sangue , Interleucina-6/imunologia , Masculino , Pessoa de Meia-Idade , Pancreatite/sangue , Estudos Retrospectivos , Síndrome de Stevens-Johnson/sangue , Síndrome de Stevens-Johnson/imunologia , Síndrome de Stevens-Johnson/mortalidade , Fator de Necrose Tumoral alfa/sangue , Fator de Necrose Tumoral alfa/imunologia , Adulto Jovem
2.
J Dermatol ; 47(2): 178-180, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31829458

RESUMO

Autoimmune progesterone dermatitis (APD) is a rare cutaneous disorder with cyclic skin eruptions during the luteal phase of the menstrual cycle. Patients can present with various clinical manifestations, including urticaria and angioedema, erythema multiforme, eczema, fixed drug eruption and centrifugal erythema annulare. In our case, however, the patient's skin lesions mimic necrotic migratory erythema (NME) which is most commonly associated with glucagonoma and rarely with liver disease, inflammatory bowel disease, malnutrition and other tumors. To our knowledge, this is the first case of NME-like APD and is successfully controlled by danazol. This also sheds lights on the etiologic diversity of NME.


Assuntos
Doenças Autoimunes/diagnóstico , Danazol/uso terapêutico , Dermatite/diagnóstico , Antagonistas de Estrogênios/uso terapêutico , Eritema Migratório Necrolítico/diagnóstico , Progesterona/efeitos adversos , Adulto , Doenças Autoimunes/complicações , Doenças Autoimunes/tratamento farmacológico , Doenças Autoimunes/imunologia , Dermatite/complicações , Dermatite/tratamento farmacológico , Dermatite/imunologia , Diagnóstico Diferencial , Feminino , Glucagonoma/complicações , Glucagonoma/diagnóstico , Humanos , Eritema Migratório Necrolítico/tratamento farmacológico , Eritema Migratório Necrolítico/imunologia , Neoplasias Pancreáticas/complicações , Neoplasias Pancreáticas/diagnóstico , Progesterona/imunologia , Pele/imunologia , Pele/patologia , Testes Cutâneos , Resultado do Tratamento
3.
Zhongguo Zhong Yao Za Zhi ; 32(6): 523-5, 2007 Mar.
Artigo em Zh | MEDLINE | ID: mdl-17552161

RESUMO

OBJECTIVE: To study the effects of Salvia miltiorrhiza on treatment of Chlamydia trachomatis salpingitis (CTS) and fibrosis. METHOD: A mouse model for CTS was estahlished in C3H/He by intravaginal inoculation. after 3 weeks mice were randomly divided into 3 groups. Only Azithromyxin was given orally, Azithromyxin and early S. miltiorrhiza given, or Azithromyxin and later S. miltiorrhiza given. After 10 weeks, observe the change of oviduct of mice, observe the histopathologic change and analysis collagen histochemical index. RESULT: 3 Treatment groups induce tubal occlusion and hydrosalpinx decreased and the collagen histochemical index decreased significantly than those of no treatment given (P < 0.05). Early S. miltiorrhiza given group induce tubal occlusion and hydrosalpinx decreased and the collagen histochemical index decreased significantly than only Azithromyxin group or later S. miltiorrhiza given group (P <0.05). CONCLUSION: When we treat CTS genital infection with Azithromyxin, if we can give S. miltiorrhiza treatment as early as possible, it may decrease tubal occlusion and hydrosalpinx. significantly inhibit fibrosis maybe one of its pharmacologic mechanismin.


Assuntos
Infecções por Chlamydia/tratamento farmacológico , Medicamentos de Ervas Chinesas/uso terapêutico , Salpingite/tratamento farmacológico , Salvia miltiorrhiza/química , Animais , Infecções por Chlamydia/complicações , Infecções por Chlamydia/microbiologia , Chlamydia trachomatis/efeitos dos fármacos , Medicamentos de Ervas Chinesas/isolamento & purificação , Doenças das Tubas Uterinas/etiologia , Doenças das Tubas Uterinas/prevenção & controle , Tubas Uterinas/efeitos dos fármacos , Tubas Uterinas/patologia , Feminino , Fibrose , Camundongos , Camundongos Endogâmicos C3H , Fitoterapia , Plantas Medicinais/química , Distribuição Aleatória , Salpingite/complicações
4.
Chin Med J (Engl) ; 130(22): 2703-2708, 2017 Nov 20.
Artigo em Inglês | MEDLINE | ID: mdl-29133759

RESUMO

BACKGROUND: Halo nevus (HN) has been shown to be associated with vitiligo, but no standard signs are currently available to identify HN patients at risk of vitiligo, and the relevant data obtained in previous studies are somewhat conflicting. This study aimed to identify factors affecting the presence of vitiligo in HN patients. METHODS: We performed a retrospective study on consecutive patients with HN at the First Affiliated Hospital of Sun Yat-sen University between January 2011 and December 2016. Detailed demographic and clinical data were collected to identify the factors associated with the presence of vitiligo in this cohort of patients using uni- and multi-variate logistic regression analyses. RESULTS: A total of 212 HN patients were included, 101 of whom had vitiligo-associated HN (HNV). Univariate analysis indicated that a personal history of thyroid diseases was positively associated with HNV (odds ratio [OR] = 10.761, P = 0.025), while the onset age of HN was negatively associated with HNV (OR = 0.537, P = 0.026). Multivariate analysis demonstrated that the Koebner phenomenon (KP; OR = 10.632, P < 0.0001), multiple HN (OR = 3.918, P < 0.0001), and a familial history of vitiligo (OR = 3.222, P = 0.014) were independent factors associated with HNV. CONCLUSIONS: HN without vitiligo has clinical features distinct from HN associated with vitiligo. HN patients with KP, multiple lesions, or familial history of vitiligo are more likely to develop vitiligo and therefore should be monitored for clinical signs of such accompanied conditions.


Assuntos
Nevo com Halo/complicações , Vitiligo/etiologia , Adolescente , Adulto , Idade de Início , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nevo com Halo/patologia , Estudos Retrospectivos , Fatores de Risco , Vitiligo/patologia , Adulto Jovem
5.
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA